NCT06976606View on ClinicalTrials.gov

A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 23, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

September 30, 2027

Conditions
Arrhythmogenic CardiomyopathyPKP2-ACMPKP2-ARVC
Trial Locations (6)

14642

RECRUITING

University of Rochester, Rochester

21044

RECRUITING

Northshore University Healthsystem Research Institute, Columbia

21287

RECRUITING

Johns Hopkins University, Baltimore

48109

RECRUITING

University of Michigan, Ann Arbor

48202

RECRUITING

Henry Ford Hospital, Detroit

94063-3126

RECRUITING

Leland Stanford Junior University, Redwood City

Sponsors

Lead Sponsor

Lexeo Therapeutics
All Listed Sponsors
lead

Lexeo Therapeutics

INDUSTRY

NCT06976606 - A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM | Biotech Hunter | Biotech Hunter